Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation

Dlouhy I; Armengol M; Recasens-Zorzo C; Ribeiro ML; Pérez-Galán P; Bosch F; López-Guillermo A; Roué G.